Edition:
United Kingdom

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

6.10USD
18 May 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.10
Open
$6.08
Day's High
$6.12
Day's Low
$5.93
Volume
5,761
Avg. Vol
56,866
52-wk High
$15.78
52-wk Low
$4.42

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

  TENX.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -1.43 -- --
ROI: -114.61 1.57 14.38
ROE: -129.29 2.43 16.07

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

16 Jan 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF77.00 -0.64
Merck & Co., Inc. (MRK.N) $59.14 +0.07
Roche Holding Ltd. (ROG.S) CHF224.55 +0.55
Roche Holding Ltd. (RO.S) CHF229.20 +1.00
Abbott Laboratories (ABT.N) $61.71 +0.65
Bayer AG (BAYGn.DE) €104.36 -0.14
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €66.44 +0.32
Eli Lilly And Co (LLY.N) $82.07 +0.41
Bristol-Myers Squibb Co (BMY.N) $52.71 -0.03

Earnings vs. Estimates